Agilon Health (AGL)
(Delayed Data from NYSE)
$1.70 USD
-0.09 (-5.03%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AGL 1.70 -0.09(-5.03%)
Will AGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGL
Alignment Healthcare (ALHC) Q2 Earnings and Revenues Surpass Estimates
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
AGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agilon Health (AGL) Reports Break-Even Earnings for Q1
Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year?
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
Other News for AGL
agilon health Sets Date to Report Second Quarter 2025 Financial Results | AGL Stock News
Agilon Health (AGL) Receives Updated Price Target from Evercore ISI Group | AGL Stock News
Where Agilon Health Stands With Analysts
New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model ...
Morgan Stanley Keeps Their Hold Rating on AGL Energy (AGLNF)